Deoxynucleoside Triphosphates Market by Type (Solid, Liquid dNTPs), End User (Research Institutes, Biotech & Pharmaceutical Companies)-Global Forecast to 2027
“Increasing research in the area of genomics, disease diagnosis, PCR amplification, target gene sequencing, and NGS are driving the growth of the market.”
The global Deoxynucleoside triphosphates Market is expected to reach USD xx billion by 2027 from USD xx billion in 2022, at a CAGR of xx%. The growth in this market is driven by the advancing genomics research, massive use of Deoxynucleoside triphosphates in the sequence based and target gene amplifications studies which are heavily utilized in the recombinant DNA technologies.
To know about the assumptions considered for the study, Request for Free Sample Report
“The liquid dNTPs segment held the largest market share in 2021.”
Based on type, the Deoxynucleoside triphosphates Market is segmented into solid and liquid Deoxynucleoside triphosphates. The liquid segment held the largest share in 2021, which is driven by its massive usage in the research areas of molecular biology, recombinant DNA technologies, PCR amplifications, and sequencing.
“The research and academic institutes segment accounted for the largest share in 2021.”
Based on the technique, the Deoxynucleoside triphosphates Market is segmented into Research and Academic Institutes, and Biotech and Pharmaceutical Companies. The Research and Academic Institutes segment held the dominating share in 2021, owing to the massive expenditure and the advanced research technologies of the PCR, NGS and Recombinant gene technologies at the research and academic bodies.
“Asia Pacific is estimated to register the highest CAGR during the study period. North America is expected to dominate the market share”
In this report, the Deoxynucleoside triphosphates Market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, Middle East & Africa and Latin America. North America to dominate the market in 2021, owing to adavnced infratsructure of research and academic, presence of leading players, and the massive prevalance of various chronic, genetic diseases and cancer.
Asia Pacific Market is expected to grow at the fastest CAGR during the forecast period of 2022 to 2027, this is attributed to the vast population base, expanding geriatric popualtion and the increasing prevalance of infections, chronic diseases and cancer are creating more demand for research and diagnosis using Deoxynucleoside triphosphates.
To know about the assumptions considered for the study, download the pdf brochure
Breakdown of primary supply-side interviews, by company type, designation, and region:
- By Company Type - Tier 1: 48%, Tier 2: 40%, and Tier 3: 12%
- By Designation - C-level: 44%, D-level: 30%, and Others: 26%
- By Region: North America (34%), Europe (26%), AsiaPacific (23%), and Rest of the World (17%)
List of Companies Profiled in the Report
- Bio Rad Laboratories, Inc.
- Thermo Fisher Scientific, Inc.
- Promega
- Creative Diagnostics
- Meridian Bioscience
- Jena Bioscience
- Takara Bio
- Geneaid
- Larova
- Boster Biological Technology
- Transgen Biotech
- Qiagen
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.4 YEARS CONSIDERED FOR THE STUDY
1.5 CURRENCY
1.6 LIMITATIONS
1.9 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 SECONDARY DATA
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.3 PRIMARY DATA
2.3.1 KEY DATA FROM PRIMARY SOURCES
2.4 MARKET SIZE ESTIMATION
2.4.1 BOTTOM-UP APPROACH
2.4.2 GROWTH FORECAST
2.4.3 TOP-DOWN APPROACH
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
2.6 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 PRICING ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.6 PORTER FIVE FORCES ANALYSIS
5.8 COVID-19 IMPACT ANALYSIS
5.9 REGULATORY LANDSCAPE
5.10 TECHNOLOGY ANALYSIS
5.11 TRADE DATA ANALYSIS
5.12 PATENT ANALYSIS
6 DEOXYNUCLEOSIDE TRIPHOSPHATES MARKET, BY TYPE
6.1 INTRODUCTION
6.2 LIQUID DNTPS
6.3 SOLID DNTPS
7 DEOXYNUCLEOSIDE TRIPHOSPHATES MARKET, BY END USER
7.1 INTRODUCTION
7.2 RESEARCH AND ACADEMICS INSTITUTES
7.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8 DEOXYNUCLEOSIDE TRIPHOSPHATES MARKET, BY REGION
8.1 NORTH AMERICA
8.1.1 US
8.1.2 CANADA
8.2 EUROPE
8.2.1 GERMANY
8.2.2 UK
8.2.3 FRANCE
8.2.4 ITALY
8.2.5 SPAIN
8.2.6 REST OF ERUOPE
8.3 ASIA-PACIFIC
8.3.1 JAPAN
8.3.2 CHINA
8.3.3 INDIA
8.3.4 REST OF ASIA-PACIFIC
8.4 LATIN AMERICA
8.5 MIDDLE EAST AND AFRICA
9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 MARKET SHARE/RANKING ANALYSIS, 2021 (IN TERMS OF % OF USD MILLION)
9.3 COMPETITIVE SCENARIO
9.3.1 PRODUCT LAUNCHES AND APPROVALS
9.3.2 PARTNERSHIPS, COLLABORATIONS, MERGERS, AND AGREEMENTS
9.3.3 EXPANSIONS
9.3.4 ACQUISITIONS
9.3.5 OTHER DEVELOPMENTS
9.4 COMPETITIVE LEADERSHIP MAPPING (2019)
9.4.1 STARS
9.4.2 EMERGING LEADERS
9.4.3 PERVASIVE
9.4.4 PARTICIPANTS
10 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
10.1 INTRODUCTION
10.2 Bio Rad Laboratories, Inc.
10.3 Thermo Fisher Scientific, Inc.
10.4 Promega
10.5 Creative Diagnostics
10.6 Meridian Bioscience
10.9 Jena Bioscience
10.9 Takara Bio
10.10 Geneaid
10.11 Larova
10.12 Boster Biological Technology
10.13 Transgen Biotech
10.14 Qiagen
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
11 APPENDIX
11.1 INSIGHTS OF INDUSTRY EXPERTS
11.2 DISCUSSION GUIDE
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.4 AVAILABLE CUSTOMIZATIONS
11.5 RELATED REPORTS
11.6 AUTHOR DETAILS
Growth opportunities and latent adjacency in Deoxynucleoside Triphosphates Market